Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1 2

Status

Completed 9Terminated 3Unknown 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Leiomyoma 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Tea × Clear all
NCT01928485 2020-10-22

Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer

Case Comprehensive Cancer Center

Phase 2 Terminated
6 enrolled 23 charts
Genitourinary

Prostatic Neoplasms

NCT01060345 2020-04-09

A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ

University of Chicago

Phase 2 Terminated
20 enrolled 5 charts
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT01311869 2013-10-24

Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids

Meharry Medical College

Phase 2 Terminated
43 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡